Clinical Trial Update: A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated lurasidone for the treatment of schizophrenia or schizoaffective disorder in patients switched from other antipsychotic medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-08-16